Sarepta Therapeutics, Inc. - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - March 14, 2011

Attached files

file filename
10-K - FORM 10-K - Sarepta Therapeutics, Inc.d10k.htm
EX-3.4 - AMENDED AND RESTATED BYLAWS OF AVI BIOPHARMA - Sarepta Therapeutics, Inc.dex34.htm
EX-4.1 - FORM OF SPECIMAN CERTIFICATE FOR COMMON STOCK - Sarepta Therapeutics, Inc.dex41.htm
EX-31.2 - SECTION 302 CFO CERTIFICATION - Sarepta Therapeutics, Inc.dex312.htm
EX-10.6 - AMENDMENT NO. 2 TO EMPLOYMENT WITH PATRICK IVERSEN, PH.D. - Sarepta Therapeutics, Inc.dex106.htm
EX-32.1 - SECTION 906 CEO CERTIFICATION - Sarepta Therapeutics, Inc.dex321.htm
EX-32.2 - SECTION 906 CFO CERTIFICATION - Sarepta Therapeutics, Inc.dex322.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - Sarepta Therapeutics, Inc.dex311.htm
EX-10.5 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH PATRICK IVERSEN PH.D. - Sarepta Therapeutics, Inc.dex105.htm
EX-10.2 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH DWIGHT WELLER - Sarepta Therapeutics, Inc.dex102.htm
EX-10.3 - AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT WITH DWIGHT WELLER - Sarepta Therapeutics, Inc.dex103.htm
EX-10.15 - EMPLOYMENT AGREEMENT BETWEEN AVI BIOPHARMA AND PAUL MEDEIROS - Sarepta Therapeutics, Inc.dex1015.htm
EX-10.10 - EMPLOYMENT AGREEMENT BETWEEN AVI BIOPHARMA AND DAVID BOYLE II - Sarepta Therapeutics, Inc.dex1010.htm
EX-10.53 - LEASE EXTENSION AND MODIFICATION AGREEMENT - Sarepta Therapeutics, Inc.dex1053.htm
EX-10.12 - AMENDMENT NO.2 TO EMPLOYMENT AGREEMENT WITH J. DAVID BOYLE II - Sarepta Therapeutics, Inc.dex1012.htm
EX-10.11 - AMENDMENT NO.1 TO EMPLOYMENT AGREEMENT BETWEEN AVI BIOPHARMA & J.DAVID BOYLE II - Sarepta Therapeutics, Inc.dex1011.htm
EX-10.17 - EXECUTIVE EMPLOYMENT AGREEMENT BETWEEN AVI BIOPHARMA & CHRISTOPHER GERABEDIAN - Sarepta Therapeutics, Inc.dex1017.htm
EX-10.36 - EXCLUSIVE LICENSE AGREEMENT BY AND BETWEEN UNIVERSITY OF WESTERN AUSTRALIA & AVI - Sarepta Therapeutics, Inc.dex1036.htm
EX-10.18 - OFFER LETTER BETWEEN AVI BIOPHARMA, INC. AND GRAHAM JOHNSON B.SC.,PH.D. - Sarepta Therapeutics, Inc.dex1018.htm
EX-10.57 - LEASE BY AND BETWEEN S/I NORTH CREEK VII LLC AND AVI BIOPHARMA - Sarepta Therapeutics, Inc.dex1057.htm
EX-10.16 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH PAUL MEDEIROS - Sarepta Therapeutics, Inc.dex1016.htm
EX-10.14 - AMENDMENT NO.1 TO EMPLOYMENT AGREEMENT WITH STEPHEN BEVAN SHREWSBERRY, M.D. - Sarepta Therapeutics, Inc.dex1014.htm
EX-10.9 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH DR. RYSZARD KOLE - Sarepta Therapeutics, Inc.dex109.htm

EXHIBIT 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors and Shareholders

AVI BioPharma, Inc.

We consent to the incorporation by reference in the registration statements (Nos. 333-160922, 333-150021, 333-133211, 333-86778, 333-105412, 333-68502, 333-45888, 333-138299, 333-93135, and 333-86039) on Form S-3 and (Nos. 333-101826, 333-49996, 333-49994, and 333-34047) on Form S-8 of AVI BioPharma, Inc. (a developmental stage company) of our report dated March 14, 2011 with respect to the balance sheets of AVI BioPharma, Inc. as of December 31, 2010 and 2009 and the related statements of operations, shareholders’ equity (deficit) and comprehensive income (loss), and cash flows for each of the years in the three-year period ended December 31, 2010 and the information included in the cumulative from inception presentations for the period January 1, 2002 to December 31, 2010 (not separately presented), and the effectiveness of internal control over financial reporting as of December 31, 2010, which reports appear in the December 31, 2010 annual report on Form 10-K of AVI BioPharma, Inc.

/s/ KPMG LLP

Seattle, Washington

March 14, 2011

Stock widget

Investing forum

Sarepta Therapeutics, Inc. Reports